Journal of Gastroenterology and Hepatology (Australia) · Published 2026-07-10 · DOI 10.1111/jgh.70555
Shu Hsien Lin, Jia‐Ling Wu, Ying‐Nan Tsai, Cheng‐Hao Tseng, Po‐Yueh Chen, Yao‐Chun Hsu
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Lin, S., Wu, J., Tsai, Y., et al. (2026). Comparative Effectiveness and Safety of Atezolizumab–Bevacizumab and Durvalumab–Tremelimumab as First‐Line Systemic Therapy for Hepatocellular Carcinoma: A Real‐World Study. Journal of Gastroenterology and Hepatology (Australia). https://doi.org/10.1111/jgh.70555